NASDAQ: MOLN
Molecular Partners Ag Stock Forecast, Predictions & Price Target

Analyst price target for MOLN

Based on 2 analysts offering 12 month price targets for Molecular Partners Ag

Min Forecast
$3.75-11.76%
Avg Forecast
$8.38+97.06%
Max Forecast
$13.00+205.88%

Should I buy or sell MOLN stock?

Based on 2 analysts offering ratings for Molecular Partners Ag.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MOLN stock forecasts and price targets.

MOLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-27
lockedlocked$00.00+00.00%2025-12-08

1 of 1

Forecast return on equity

Is MOLN forecast to generate an efficient return?

Company
-63.93%
Industry
352.12%
Market
211.34%
MOLN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MOLN forecast to generate an efficient return on assets?

Company
-54.46%
Industry
122.26%
MOLN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MOLN earnings per share forecast

What is MOLN's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.52
Avg 2 year Forecast
-$0.46
Avg 3 year Forecast
-$3.13

MOLN revenue forecast

What is MOLN's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$7.5M
Avg 2 year Forecast
$36.7M
Avg 3 year Forecast
$51.3M

MOLN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MOLN$4.25$8.38+97.06%Buy
IPHA$1.83$5.00+173.22%Buy
IRD$2.31$8.00+246.32%Strong Buy
NKTX$2.22$10.50+372.97%Strong Buy
ABOS$2.60$7.50+188.46%Strong Buy

Molecular Partners Ag Stock Forecast FAQ

Is Molecular Partners Ag Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: MOLN) stock is to Buy MOLN stock.

Out of 2 analysts, 0 (0%) are recommending MOLN as a Strong Buy, 1 (50%) are recommending MOLN as a Buy, 1 (50%) are recommending MOLN as a Hold, 0 (0%) are recommending MOLN as a Sell, and 0 (0%) are recommending MOLN as a Strong Sell.

If you're new to stock investing, here's how to buy Molecular Partners Ag stock.

What is MOLN's earnings growth forecast for 2026-2028?

(NASDAQ: MOLN) Molecular Partners Ag's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.

Molecular Partners Ag's earnings in 2026 is -$74,362,962.On average, 5 Wall Street analysts forecast MOLN's earnings for 2026 to be -$56,701,767, with the lowest MOLN earnings forecast at -$72,189,681, and the highest MOLN earnings forecast at -$23,164,564. On average, 4 Wall Street analysts forecast MOLN's earnings for 2027 to be -$17,163,091, with the lowest MOLN earnings forecast at -$86,114,594, and the highest MOLN earnings forecast at $56,929,860.

In 2028, MOLN is forecast to generate -$117,079,203 in earnings, with the lowest earnings forecast at -$112,487,422 and the highest earnings forecast at -$120,523,039.

What is MOLN's revenue growth forecast for 2026-2028?

(NASDAQ: MOLN) Molecular Partners Ag's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.

Molecular Partners Ag's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast MOLN's revenue for 2026 to be $279,694,815, with the lowest MOLN revenue forecast at $0, and the highest MOLN revenue forecast at $863,763,401. On average, 5 Wall Street analysts forecast MOLN's revenue for 2027 to be $1,373,047,276, with the lowest MOLN revenue forecast at $0, and the highest MOLN revenue forecast at $4,240,293,057.

In 2028, MOLN is forecast to generate $1,919,312,190 in revenue, with the lowest revenue forecast at $1,844,041,379 and the highest revenue forecast at $1,975,737,253.

What is MOLN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MOLN) forecast ROA is -54.46%, which is lower than the forecast US Biotechnology industry average of 122.26%.

What is MOLN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MOLN price target, the average MOLN price target is $8.38, with the highest MOLN stock price forecast at $13.00 and the lowest MOLN stock price forecast at $3.75.

On average, Wall Street analysts predict that Molecular Partners Ag's share price could reach $8.38 by Jan 27, 2027. The average Molecular Partners Ag stock price prediction forecasts a potential upside of 97.06% from the current MOLN share price of $4.25.

What is MOLN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MOLN) Molecular Partners Ag's current Earnings Per Share (EPS) is -$2.00. On average, analysts forecast that MOLN's EPS will be -$1.52 for 2026, with the lowest EPS forecast at -$1.93, and the highest EPS forecast at -$0.62. On average, analysts forecast that MOLN's EPS will be -$0.46 for 2027, with the lowest EPS forecast at -$2.30, and the highest EPS forecast at $1.52. In 2028, MOLN's EPS is forecast to hit -$3.13 (min: -$3.01, max: -$3.22).

What is MOLN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MOLN) forecast ROE is -63.93%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.